drugset / Trial / NCT04959240

Expanded Access to Velmanase Alfa

NCT04959240 ↗

Expanded access Available Chiesi Farmaceutici S.p.A.

Summary

Individual patient expanded access requests may be considered for patients who have no other treatment options.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Velmanase Alfa Protein / enzyme biologic — —

Indications